KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Medpace Holdings (MEDP) over the last 9 years, with Q3 2025 value amounting to $12.2 million.

  • Medpace Holdings' Treasury Shares changed 0.0% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $12.2 million for FY2024, which is 70.61% down from last year.
  • As of Q3 2025, Medpace Holdings' Treasury Shares stood at $70073.0, which was down 0.0% from $70073.0 recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Treasury Shares ranged from a high of $602187.0 in Q4 2021 and a low of $70073.0 during Q1 2024
  • For the 5-year period, Medpace Holdings' Treasury Shares averaged around $142004.5, with its median value being $70573.0 (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 15534.24% in 2022, then crashed by 1348.73% in 2023.
  • Medpace Holdings' Treasury Shares (Quarter) stood at $5.4 million in 2021, then skyrocketed by 130.27% to $12.5 million in 2022, then fell by 1.4% to $12.3 million in 2023, then fell by 0.71% to $12.2 million in 2024, then changed by 0.0% to $12.2 million in 2025.
  • Its Treasury Shares stands at $12.2 million for Q3 2025, versus $12.2 million for Q2 2025 and $12.2 million for Q1 2025.